L1CAM is expressed in triple-negative breast cancers and is inversely correlated with Androgen receptor

Abstract

These results suggest that L1CAM in breast cancer is under AR control. The data also strongly advocate the use of L1CAM assessment in breast cancer diagnosis. We suggest that L1CAM expression could be causally related to the bad prognosis of TNBCs.